ENTITY

Royalty Pharma (RPRX US)

16
Analysis
Health CareUnited States
Royalty Pharma plc acquires biopharmaceutical royalties. The Company funds innovation directly when it partners with companies to co-fund late-stage clinical trials and new product launches in exchange for future royalties, and indirectly when it acquires existing royalties from the original innovators.
more
Company Presentation05 Nov 2025 21:00
Company Presentation11 Sep 2025 20:30
Company Presentation06 Aug 2025 20:00
Company Presentation08 May 2025 20:30
Company Presentation11 Feb 2025 21:30
x